Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
Authors
Keywords
TET, 5-Hydroxymethylcytosine, DNA methylation, 5-Azacytidine, Cancer biomarker
Journal
Clinical Epigenetics
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-11
DOI
10.1186/s13148-015-0133-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetics in Gastric Carcinogenesis: Tet Genes as Important Players
- (2015) Laura Georgiana Necula et al. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
- Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
- (2015) Michael Christoph Haffner et al. Oncotarget
- Early-onset colorectal cancer patients without family history are “at very low risk” for lynch syndrome
- (2014) Vittoria Stigliano et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- 5-Hydroxymethylcytosine and disease
- (2014) Jingyu Wang et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- 5-Azacytidine Improves the Osteogenic Differentiation Potential of Aged Human Adipose-Derived Mesenchymal Stem Cells by DNA Demethylation
- (2014) Xueying Yan et al. PLoS One
- Connections between TET proteins and aberrant DNA modification in cancer
- (2014) Yun Huang et al. TRENDS IN GENETICS
- DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma
- (2014) Sumadi Lukman Anwar WORLD JOURNAL OF GASTROENTEROLOGY
- R-2-Hydroxyglutarate as the Key Effector of IDH Mutations Promoting Oncogenesis
- (2013) Dan Ye et al. CANCER CELL
- Decrease of Global Methylation Improves Significantly Hepatic Differentiation of Ad-MSCs: Possible Future Application for Urea Detoxification
- (2013) C. Seeliger et al. CELL TRANSPLANTATION
- TET enzymes, TDG and the dynamics of DNA demethylation
- (2013) Rahul M. Kohli et al. NATURE
- Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1
- (2013) Chungang Liu et al. PLoS One
- Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
- (2013) Johanna Dzieran et al. PLoS One
- Epigenetic regulation in adult stem cells and cancers
- (2013) Lama Tarayrah et al. Cell and Bioscience
- Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function
- (2013) Maxim Ivanov et al. GENOME BIOLOGY
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Tet family proteins and 5-hydroxymethylcytosine in development and disease
- (2012) L. Tan et al. DEVELOPMENT
- Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
- (2012) H Yang et al. ONCOGENE
- TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
- (2012) Chih-Hung Hsu et al. Cell Reports
- Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism
- (2011) Jie Lin et al. ARCHIVES OF TOXICOLOGY
- Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond
- (2011) Junjie U. Guo et al. CELL CYCLE
- Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
- (2011) Naoshi Nishida et al. CURRENT GENOMICS
- Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
- (2011) H. Wu et al. GENES & DEVELOPMENT
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Genome-wide Regulation of 5hmC, 5mC, and Gene Expression by Tet1 Hydroxylase in Mouse Embryonic Stem Cells
- (2011) Yufei Xu et al. MOLECULAR CELL
- Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma
- (2011) Daniel Krell et al. PLoS One
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
- (2011) Y.-F. He et al. SCIENCE
- Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
- (2011) S. Ito et al. SCIENCE
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
- (2010) Shinsuke Ito et al. NATURE
- Quantification of Fluorescence Intensity of Labeled Human Mesenchymal Stem Cells and Cell Counting of Unlabeled Cells in Phase-Contrast Imaging: An Open-Source-Based Algorithm
- (2010) Hans Polzer et al. TISSUE ENGINEERING PART C-METHODS
- IDH mutations in glioma and acute myeloid leukemia
- (2010) Lenny Dang et al. TRENDS IN MOLECULAR MEDICINE
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
- (2008) Elizabeth A. Griffiths et al. SEMINARS IN HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started